There is no evidence-based medical evidence on whether postoperative adjuvant therapy can improve the survival of patients with uterine sarcoma. 2. The drugs that have a better effect on sarcoma chemotherapy are cisplatin, adriamycin, isocyclophosphamide, commonly used in combination with two or three drugs. 3. The toxic side effects of chemotherapy are heavy, 4. High dose and high efficiency are appropriate. 5. Prognosis High recurrence rate and poor prognosis. Relatively low grade malignant endometrial mesenchymal sarcoma has a better prognosis.